SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Insite Vision Inc.
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Cheryl Galt who wrote (552)12/3/1997 5:08:00 PM
From: Robert Mayo  Read Replies (1) of 1060
 
Cherly,

Thanks for the link.

I noticed BetaSite, PilaSite and MethaSite were no longer listed on Insite's web page, insitevision.com.

A few months ago I asked Mike Baer what had become of the three Phase III drugs and he remarked that their fate was pretty much out of INSVs hands. Rights to two of them had been sold and final FDA approval would depend on the acquiring pharma; and the third probably didn't have a big enough market to continue to pursue approval/production.

Insite's product portfolio still looks good, development news is also good, and nobody is paying attention. It's frustrating. It's been frustrating for two years. Hopefully, Kumar will get the major deals done, we'll have a good H&Q conference and some money managers will finally pay attention.

Don't know if 208 will beat 205 to market. I'll try to find out.

Bob
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News